Caseware UK (AP4) 2024.0.164 2024.0.164 2025-12-31 2025-12-31 true false 2025-01-01 false Other research and experimental development on natural sciences andengineering 4 6 false 14567922 2025-01-01 2025-12-31 14567922 2024-01-01 2024-12-31 14567922 2025-12-31 14567922 2024-12-31 14567922 c:Director1 2025-01-01 2025-12-31 14567922 c:Director2 2025-01-01 2025-12-31 14567922 d:CurrentFinancialInstruments 2025-12-31 14567922 d:CurrentFinancialInstruments 2024-12-31 14567922 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 14567922 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 14567922 d:ShareCapital 2025-12-31 14567922 d:ShareCapital 2024-12-31 14567922 d:RetainedEarningsAccumulatedLosses 2025-12-31 14567922 d:RetainedEarningsAccumulatedLosses 2024-12-31 14567922 c:OrdinaryShareClass1 2025-01-01 2025-12-31 14567922 c:OrdinaryShareClass1 2025-12-31 14567922 c:OrdinaryShareClass1 2024-12-31 14567922 c:FRS102 2025-01-01 2025-12-31 14567922 c:Audited 2025-01-01 2025-12-31 14567922 c:FullAccounts 2025-01-01 2025-12-31 14567922 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14567922 c:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 14567922 2 2025-01-01 2025-12-31 14567922 7 2025-01-01 2025-12-31 14567922 e:Finland 2025-01-01 2025-12-31 14567922 f:PoundSterling 2025-01-01 2025-12-31 xbrli:shares iso4217:GBP xbrli:pure

Company Registration Number: 14567922 NANOFORM U.K. LTD FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
NANOFORM U.K. LTD REGISTERED NUMBER: 14567922 STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2025
|  | 2025 |  | 2024
Note |  | £ |  | £
Current assets |  |  |  |  |
Debtors: amounts falling due within one year | 4 | 129,855 |  | 156,263 |
Cash at bank and in hand |  | 61,289 |  | 69,749 |
|  | 191,144 |  | 226,012 |
Creditors: amounts falling due within one year | 5 | (79,950) |  | (147,808) |
Net current assets |  |  | 111,194 |  | 78,204
Total assets less current liabilities |  |  | 111,194 |  | 78,204
Net assets |  |  | 111,194 |  | 78,204
Capital and reserves |  |  |  |  |
Called up share capital | 6 |  | 1,000 |  | 1,000
Profit and loss account |  |  | 110,194 |  | 77,204
|  |  | 111,194 |  | 78,204
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
Edvard Olof Haeggstrom | Christian Jones
Director | Director
Date: 25 June 2026 |
The notes on pages 2 to 6 form part of these financial statements. Page 1
NANOFORM U.K. LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
1. | General information
Nanoform U.K. Ltd is a private company limited by shares, incorporated in England with company registration number 14567922. It's registered office is James Watson House, Montgomery Way, Rosehill Industrial Estate, Carlisle, CA1 2UU. The financial statements have been presented in Pounds Sterling, which is the functional currency of the company. 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
| 2.2 | Going concern
The company operates on a cost-plus revenue basis under an agreement with its parent company, Nanoform Finland OYJ. The parent company has confirmed its intention to continue operating under this arrangement for a period of at least 12 months from the date of approval of these financial statements. In making their assessment, the directors have considered the company's forecast cash flows, the continued operation of the cost-plus agreement and the financial position of the wider group. Based on the confirmation received from the parent company and the directors' assessment of the group's plans and available resources, the directors have a reasonable expectation that the company will continue to have adequate resources to meet its obligations as they fall due for the foreseeable future. Accordingly, the directors continue to adopt the going concern basis in preparing the financial statements.
| 2.3 | Turnover
The Company provides management services, with sales based on the costs incurred by the company plus a markup in accordance with the contract to provide the services. Turnover is recognised in the accounting period in which the management services are rendered, being the accounting period in which the cost is incurred by the Company. Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
| 2.4 | Interest income
Interest income is recognised in profit or loss using the effective interest method.
| 2.5 | Finance costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument. Page 2
NANOFORM U.K. LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 2.Accounting policies (continued)
| 2.6 | Pensions
Defined contribution pension plan The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations. The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.
| 2.7 | Taxation
Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively. The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.
| 2.8 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.9 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Bank balances are measured at amortised cost, which is considered to be equal to their nominal value due to their short-term nature.
| 2.10 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method. Page 3
NANOFORM U.K. LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 2.Accounting policies (continued)
| 2.11 | Holiday pay accrual
A liability is recognised to the extent of any unused holiday pay entitlement which is accrued at the reporting date and carried forward to future periods. This is measured at the undiscounted salary cost of the future holiday entitlement so accrued at the reporting date.
| 2.12 | Financial instruments
Financial instruments are recognised in the Company's Statement of Financial Position when the Company becomes party to the contractual provisions of the instrument. Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. Basic financial assets Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments. Impairment of financial assets Financial assets are assessed for indicators of impairment at each reporting date. Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate. If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss. Financial liabilities Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities. Basic financial liabilities, which include trade and other payables, are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial. Debt instruments are subsequently carried at their amortised cost using the effective interest rate method. Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is Page 4
NANOFORM U.K. LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025 2.Accounting policies (continued)
| 2.12 | Financial instruments (continued)
due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial. Derecognition of financial assets Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained. Derecognition of financial liabilities Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.
3. | Employees
| The average monthly number of employees, including directors, during the year was 4 (2024 - 6).
4. | Debtors
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Amounts owed by group undertakings | 128,476 | 151,131
| Other debtors | 1,379 | 1,836
| Prepayments and accrued income | - | 3,296
|  | 129,855 | 156,263
5. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
| Trade creditors | 1 | 1,124
| Corporation tax | 10,546 | 14,534
| Other taxation and social security | 25,681 | 28,362
| Accruals and deferred income | 43,722 | 103,788
|  | 79,950 | 147,808
Page 5
NANOFORM U.K. LTD NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
6. | Share capital
|  |  |  |  | 2025 | 2024
|  |  |  |  | £ | £
|  | Allotted, called up and fully paid |  |
|  | 1,000 (2024 - 1,000) Ordinary shares of £1.00 each | 1,000 | 1,000
7. | Pension commitments
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £25,355 (2024 - £28,583). Contributions totalling £4,832 (2024 - £4,485) were payable to the fund at the reporting date and are included in creditors.
8. | Controlling party
The parent undertaking of the smallest and largest group within which the company belongs and for which group financial statements are prepared is Nanoform Finland OYJ, registered office Cultivator II, Viinkinaari 4, FI-00790, Helsinki, Finland, which is also the company's ultimate parent undertaking.
9. | Auditors' information
The auditors' report on the financial statements for the year ended 31 December 2025 was unqualified. The audit report was signed on 29 June 2026 by Jack Steer BA(Hons) FCA (Senior Statutory Auditor) on behalf of MHA Audit Services LLP.
Page 6